Tag: Lucentis

Over 1.5 million people are threatened by wet age-related macular degeneration (AMD), which has been effectively treated with eye injections that can prevent vision loss. The question of what is the best injection for macular degeneration depends on the specific type of AMD, the medication's mechanism, and the patient's individual needs.

The list price for Lucentis (ranibizumab), often misspelled as Accentrix, can be approximately $1,575 to $2,000 per injection [1.2.2, 1.2.4]. What is the cost of Accentrix injection and what factors determine the final price for patients needing this critical eye treatment?

Approximately 20 million Americans have some form of age-related macular degeneration (AMD), a condition often managed with intravitreal injections [1.9.1]. A common question for patients is, **how long do eye injections last?** The answer depends on the medication, the condition being treated, and individual patient response.